Low Back Pain Clinical Trial
— TIOKETOfficial title:
Efficacy and Safety of a Fixed Combination (Thiocolchicoside 8 mg + Ketoprofen 100 mg ) Compared to Thiocolchicoside 8 mg Administered Twice a Day for 7 Days in Patients Suffering From Acute Non Specific Low Back Pain
Primary Objective :
To demonstrate the superiority of the oral fixed - combination of a muscle relaxant,
thiocolchicoside (TCC) to a non steroidal anti-inflammatory drug, ketoprofen, over oral TCC,
on average pain within the last 24 hours in adults suffering from acute non specific low
back pain with an episode of recent onset
Secondary Objective :
To compare the safety of the oral combination to that of oral TCC alone
Status | Completed |
Enrollment | 334 |
Est. completion date | June 2009 |
Est. primary completion date | June 2009 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 20 Years to 55 Years |
Eligibility |
List of Inclusion and Exclusion criteria : Inclusion Criteria: - Non specific low back pain with an acute episode of recent onset (<48 hours) defined by average pain within the last 24 hours equal or more than 50 mm on the Visual Analogue Scale (VAS) - Low back pain of diagnosis category 1 (low back pain radiating no farther than the intergluteal fold) or 2 (low back pain radiating no farther than the knee), as defined by the International Paris Task Force on Back Pain Exclusion Criteria: Exclusion criteria related to study methodology: - Low back pain due to vertebral collapse or of no mechanical origin (suspected by history taking and physical examination), such as neoplasm, infection or inflammatory disorders, - Low back pain of diagnosis category 3 (low back pain radiating beyond the knee, with no neurologic signs) or 4 (low back pain radiating to a precise and entire leg dermatome, with or without neurologic signs), as defined by the International Paris Task Force on Back Pain - History of inflammatory arthritis of large joints, - History of seizure disorders, - History of malignant tumour, - Treatment with steroidal agents (including aspirin) during the two days prior to prospective inclusion, prolonged used of corticosteroids, - Treatment with NSAIDs or muscle relaxant or opioid analgesics within 3 days of admission, - Psychiatric or mental diseases, - Immunosuppression, HIV, - Inclusion in another study in the past six months or previous inclusion in this study, - History of alcohol, drugs or narcotics abuse - Recent history of violent trauma, - Constant progressive, non mechanical pain (no relief with bed rest), - Thoracic pain, - Patient systemically unwell, - Unexplained weight loss, - Widespread neurological symptoms (including cauda equine syndrome), - Structural deformity - Fever, - Clinical significant renal dysfunction defined by Creatinine > 1.5 UNL, - Clinically significant hepatic dysfunction defined by: - Total Bilirubin > 2 UNL - SGOT (AST) > 1.5 UNL - SGPT (ALAT) > 1.5 UNL - Alkaline Phosphatase > 1.5 UNL - Patients who have received other therapy (physiotherapy, physical manipulations, invasive intervention, acupuncture therapy...) within the last 48 hours. Exclusion criteria related to trial drugs: - Pregnancy, breast feeding or women of childbearing potential not using efficient contraception. Patient with Intra Uterine Device should use another form of contraception as the efficacy of the IUD may be reduced by ketoprofen. Exclusion criteria related to thiocolchicoside: - Known or suspected hypersensitivity to thiocolchicoside Exclusion criteria related to ketoprofen: - Uncontrolled heart failure, - Arterial Hypertension (SBP>140 mmHg or DBP >90 mmHg), - Stroke or myocardial infarction in the past, - Myopathy - Myasthenia, - History of active peptic ulcer or gastrointestinal (GI) bleeding, history of gastric pain with NSAIDs, - History of NSAID/aspirin-induced asthma, - Known or suspected hypersensitivity to ketoprofen. The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial. |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Brazil | Sanofi-Aventis Administrative Office | Sao Paulo | |
Colombia | Sanofi-Aventis Administrative Office | Bogota | |
Egypt | Sanofi-Aventis Administrative Office | Cairo | |
Guatemala | Sanofi-Aventis Administrative Office | Guatemala City | |
Mexico | Sanofi-Aventis Administrative Office | Col. Coyoacan | |
Venezuela | Sanofi-Aventis Administrative Office | Caracas |
Lead Sponsor | Collaborator |
---|---|
Sanofi |
Brazil, Colombia, Egypt, Guatemala, Mexico, Venezuela,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Average pain within the last 24 hours (VAS) | at D3 visit | No | |
Secondary | Average pain within the last 24 hours (VAS) | at D7 visit | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03916705 -
Thoraco-Lumbar Fascia Mobility
|
N/A | |
Completed |
NCT04007302 -
Modification of the Activity of the Prefrontal Cortex by Virtual Distraction in the Lumbago
|
N/A | |
Completed |
NCT03273114 -
Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain
|
N/A | |
Recruiting |
NCT03600207 -
The Effect of Diaphragm Muscle Training on Chronic Low Back Pain
|
N/A | |
Completed |
NCT04284982 -
Periodized Resistance Training for Persistent Non-specific Low Back Pain
|
N/A | |
Recruiting |
NCT05600543 -
Evaluation of the Effect of Lumbar Belt on Spinal Mobility in Subjects With and Without Low Back Pain
|
N/A | |
Withdrawn |
NCT05410366 -
Safe Harbors in Emergency Medicine, Specific Aim 3
|
||
Completed |
NCT03673436 -
Effect of Lumbar Spinal Fusion Predicted by Physiotherapists
|
||
Completed |
NCT02546466 -
Effects of Functional Taping on Static Postural Control in Patients With Non-specific Chronic Low Back Pain
|
N/A | |
Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
Recruiting |
NCT05156242 -
Corticospinal and Motor Behavior Responses After Physical Therapy Intervention in Patients With Chronic Low Back Pain.
|
N/A | |
Recruiting |
NCT04673773 -
MY RELIEF- Evidence Based Information to Support People Aged 55+ Years Living and Working With Persistent Low-back Pain.
|
N/A | |
Completed |
NCT06049251 -
ELDOA Technique Versus Lumbar SNAGS With Motor Control Exercises
|
N/A | |
Completed |
NCT06049277 -
Mulligan Technique Versus McKenzie Extension Exercise Chronic Unilateral Radicular Low Back Pain
|
N/A | |
Completed |
NCT04980469 -
A Study to Explore the Effect of Vitex Negundo and Zingiber Officinale on Non-specific Chronic Low Back Pain Due to Sedentary Lifestyle
|
N/A | |
Completed |
NCT04055545 -
High Intensity Interval Training VS Moderate Intensity Continuous Training in Chronic Low Back Pain Subjects
|
N/A | |
Recruiting |
NCT05552248 -
Assessment of the Safety and Performance of a Lumbar Belt
|
||
Recruiting |
NCT05944354 -
Wearable Spine Health System for Military Readiness
|
||
Completed |
NCT05801588 -
Participating in T'ai Chi to Reduce Back Pain and Improve Quality of Life
|
N/A | |
Completed |
NCT05811143 -
Examining the Effects of Dorsal Column Stimulation on Pain From Lumbar Spinal Stenosis Related to Epidural Lipomatosis.
|